Marc Tessier Lavigne Denali Therapeutics Inc. (DNLI) insider trading activity
Marc Tessier Lavigne is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 1.88 Million shares of DNLI, which is worth approximately $39.1 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 5,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.88M
0%
3M change
0.32%
12M change
Total Value Held
$39.1 Million
Marc Tessier-Lavigne Transaction History
Also insider at
MT
Marc Tessier Lavigne
Director
South San Francisco, CA